These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 25342064)

  • 1. Whole exome sequencing in family trios reveals de novo mutations in PURA as a cause of severe neurodevelopmental delay and learning disability.
    Hunt D; Leventer RJ; Simons C; Taft R; Swoboda KJ; Gawne-Cain M; ; Magee AC; Turnpenny PD; Baralle D
    J Med Genet; 2014 Dec; 51(12):806-13. PubMed ID: 25342064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient with a novel purine-rich element binding protein A mutation.
    Okamoto N; Nakao H; Niihori T; Aoki Y
    Congenit Anom (Kyoto); 2017 Nov; 57(6):201-204. PubMed ID: 28164378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the phenotype of PURA-related neurodevelopmental disorder: a close differential diagnosis of infantile hypotonia with psychomotor retardation and characteristic facies.
    Mishra S; Girisha KM; Shukla A
    Clin Dysmorphol; 2021 Jan; 30(1):1-5. PubMed ID: 33229923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel
    Rodríguez-García ME; Cotrina-Vinagre FJ; Arranz-Canales E; Aragón AM; Hernández-Sánchez L; Rodríguez-Fornés F; Carnicero-Rodríguez P; Morales-Conejo M; Martín-Hernández E; Martínez-Azorín F
    J Genet; 2020; 99():. PubMed ID: 32089526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PURA syndrome: clinical delineation and genotype-phenotype study in 32 individuals with review of published literature.
    Reijnders MRF; Janowski R; Alvi M; Self JE; van Essen TJ; Vreeburg M; Rouhl RPW; Stevens SJC; Stegmann APA; Schieving J; Pfundt R; van Dijk K; Smeets E; Stumpel CTRM; Bok LA; Cobben JM; Engelen M; Mansour S; Whiteford M; Chandler KE; Douzgou S; Cooper NS; Tan EC; Foo R; Lai AHM; Rankin J; Green A; Lönnqvist T; Isohanni P; Williams S; Ruhoy I; Carvalho KS; Dowling JJ; Lev DL; Sterbova K; Lassuthova P; Neupauerová J; Waugh JL; Keros S; Clayton-Smith J; Smithson SF; Brunner HG; van Hoeckel C; Anderson M; Clowes VE; Siu VM; Ddd Study T; Selber P; Leventer RJ; Nellaker C; Niessing D; Hunt D; Baralle D
    J Med Genet; 2018 Feb; 55(2):104-113. PubMed ID: 29097605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expanding the PURA syndrome phenotype: A child with the recurrent PURA p.(Phe233del) pathogenic variant showing similarities with cutis laxa.
    Cinquina V; Ciaccio C; Venturini M; Masson R; Ritelli M; Colombi M
    Mol Genet Genomic Med; 2021 Jan; 9(1):e1562. PubMed ID: 33275834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding the neurodevelopmental phenotype of PURA syndrome.
    Lee BH; Reijnders MRF; Abubakare O; Tuttle E; Lape B; Minks KQ; Stodgell C; Bennetto L; Kwon J; Fong CT; Gripp KW; Marsh ED; Smith WE; Huq AM; Coury SA; Tan WH; Solis O; Mehta RI; Leventer RJ; Baralle D; Hunt D; Paciorkowski AR
    Am J Med Genet A; 2018 Jan; 176(1):56-67. PubMed ID: 29150892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the clinical phenotype and genetic spectrum of PURA-related neurodevelopmental disorders.
    Choi SA; Lee HS; Park TJ; Park S; Ko YJ; Kim SY; Lim BC; Kim KJ; Chae JH
    Brain Dev; 2021 Oct; 43(9):912-918. PubMed ID: 34116881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel familial autosomal dominant mutation in ARID1B causing neurodevelopmental delays, short stature, and dysmorphic features.
    Smith JA; Holden KR; Friez MJ; Jones JR; Lyons MJ
    Am J Med Genet A; 2016 Dec; 170(12):3313-3318. PubMed ID: 27570168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo missense variants in MEIS2 recapitulate the microdeletion phenotype of cardiac and palate abnormalities, developmental delay, intellectual disability and dysmorphic features.
    Douglas G; Cho MT; Telegrafi A; Winter S; Carmichael J; Zackai EH; Deardorff MA; Harr M; Williams L; Psychogios A; Erwin AL; Grebe T; Retterer K; Juusola J
    Am J Med Genet A; 2018 Sep; 176(9):1845-1851. PubMed ID: 30055086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome sequencing identified a de novo mutation of PURA gene in a patient with familial Xp22.31 microduplication.
    Qiao Y; Bagheri H; Tang F; Badduke C; Martell S; Lewis SME; Robinson W; Connolly MB; Arbour L; Rajcan-Separovic E
    Eur J Med Genet; 2019 Feb; 62(2):103-108. PubMed ID: 29908350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 25 Mainland Chinese cohort of patients with PURA-related neurodevelopmental disorders: clinical delineation and genotype-phenotype correlations.
    Dai W; Sun Y; Fan Y; Gao Y; Zhan Y; Wang L; Xiao B; Qiu W; Gu X; Sun K; Yu Y; Xu N
    Eur J Hum Genet; 2023 Jan; 31(1):112-121. PubMed ID: 36376392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new case with the recurrent PURA p.(Phe233del) pathogenic variant: Expansion of the phenotype and review of the literature.
    Ben Issa A; Ben Ayed I; Jallouli O; Souissi A; Bouchaalla W; Ben Said M; Mallouli S; Masmoudi S; Charfi Triki C; Hadj Kacem H; Kammoun F
    Int J Dev Neurosci; 2023 Jun; 83(4):383-395. PubMed ID: 37204304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncating de novo mutations in the Krüppel-type zinc-finger gene ZNF148 in patients with corpus callosum defects, developmental delay, short stature, and dysmorphisms.
    Stevens SJ; van Essen AJ; van Ravenswaaij CM; Elias AF; Haven JA; Lelieveld SH; Pfundt R; Nillesen WM; Yntema HG; van Roozendaal K; Stegmann AP; Gilissen C; Brunner HG
    Genome Med; 2016 Dec; 8(1):131. PubMed ID: 27964749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PURA syndrome in a child with severe developmental delay: a challenging diagnosis.
    Nogueira M; Melo C; Grangeia A; Magalhães T; Soares C; Dias R; Fonseca J; Sampaio M; Sousa R
    Rev Neurol; 2022 Mar; 74(5):170-173. PubMed ID: 35211951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular and Neuromuscular Junction Manifestations of the PURA-NDD: A Systematic Review of the Reported Symptoms and Potential Treatment Options.
    Mroczek M; Iyadurai S
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in manifestations of epilepsy and developmental delay in PURA syndrome and 5q31 microdeletions.
    Kofoed AWS; Kristiansen SS; Miranda MJ; Rubboli G; Johannesen KM
    Clin Genet; 2024 Oct; 106(4):386-393. PubMed ID: 38923490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exome sequencing analysis in a pair of monozygotic twins re-evaluates the genetics behind their intellectual disability and reveals a CHD2 mutation.
    Pinto AM; Bianciardi L; Mencarelli MA; Imperatore V; Di Marco C; Furini S; Suppiej A; Salviati L; Tenconi R; Ariani F; Mari F; Renieri A
    Brain Dev; 2016 Jun; 38(6):590-6. PubMed ID: 26754451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo mutations in PURA are associated with hypotonia and developmental delay.
    Tanaka AJ; Bai R; Cho MT; Anyane-Yeboa K; Ahimaz P; Wilson AL; Kendall F; Hay B; Moss T; Nardini M; Bauer M; Retterer K; Juusola J; Chung WK
    Cold Spring Harb Mol Case Stud; 2015 Oct; 1(1):a000356. PubMed ID: 27148565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
    DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
    J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.